Growth Metrics

Medpace Holdings (MEDP) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to $4.64.

  • Medpace Holdings' EPS (Weighted Average and Diluted) rose 2643.05% to $4.64 in Q4 2025 from the same period last year, while for Dec 2025 it was $15.27, marking a year-over-year increase of 2090.26%. This contributed to the annual value of $15.28 for FY2025, which is 2098.18% up from last year.
  • Latest data reveals that Medpace Holdings reported EPS (Weighted Average and Diluted) of $4.64 as of Q4 2025, which was up 2643.05% from $3.86 recorded in Q3 2025.
  • In the past 5 years, Medpace Holdings' EPS (Weighted Average and Diluted) ranged from a high of $4.64 in Q4 2025 and a low of $1.06 during Q2 2021
  • Its 5-year average for EPS (Weighted Average and Diluted) is $2.44, with a median of $2.24 in 2023.
  • Within the past 5 years, the most significant YoY rise in Medpace Holdings' EPS (Weighted Average and Diluted) was 6562.5% (2021), while the steepest drop was 149.25% (2021).
  • Over the past 5 years, Medpace Holdings' EPS (Weighted Average and Diluted) (Quarter) stood at $1.32 in 2021, then skyrocketed by 59.09% to $2.1 in 2022, then increased by 17.14% to $2.46 in 2023, then surged by 49.19% to $3.67 in 2024, then rose by 26.43% to $4.64 in 2025.
  • Its last three reported values are $4.64 in Q4 2025, $3.86 for Q3 2025, and $3.1 during Q2 2025.